Dr Shobhana Nagraj (HSC) was awarded an Oxford Policy Engagement Network (OPEN) Fellowship to work alongside Good Food Oxfordshire and Oxfordshire County Council to hold a roundtable on addressing child food poverty in Oxfordshire. Entitled \u2018Listen & act: accessing healthy, affordable food for Oxfordshire\u2019s children\u2019, the event brought together key actors and stakeholders from across Oxfordshire, and resulted in a report with three key policy recommendations to improve childhood nutrition in Oxfordshire.
Professor Deirdre Hollingsworth, Professor of Infectious Disease Epidemiology has been named as one of this year\u2019s 50 Leading Lights for Kindness & Leadership in the UK. This campaign highlights the leaders who are impacting others through kindness.
Handheld Spatially Offset Raman Spectroscopy (SORS) devices offer new hope for easily detecting falsified COVID-19 vaccines \u2014 even if the vaccine vials are unopened, say researchers in a paper published in Vaccine on 20 Oct 2023
The Global Health Network and the British Society for Antimicrobial Chemotherapy (BSAC) have signed a Memorandum of Understanding (MoU) establishing a framework for collaboration that can maximise the impact of shared antimicrobial resistance education, policy and advocacy efforts.
In a world driven by innovation and technology, healthcare remains a cornerstone of society. Understanding the healthcare system's challenges is crucial for professionals and the public. As part of our ongoing commitment to fostering knowledge and awareness the Health Systems Collaborative (HSC) team participated in community engagement as a part of the IF Oxford Science and Ideas Festival. This event allowed participants to explore the human resources for health challenges while highlighting our work to address these issues in the UK and worldwide.
A collaborative study by researchers from the Institut de Recherche en Sciences de La Sant\u00e9 of Nanoro (IRRS-Nanoro) in Burkina Faso and IDDO/WWARN has found that giving young children vitamin and lipid supplements at the same time as seasonal malaria chemoprevention reduces the incidence of severe malaria by approx. 50%, compared to chemoprevention alone.
OUCRU will be a part of a new initiative aimed at developing a strategic roadmap for Ho Chi Minh City to become a regional Health Innovation Hub. The project, supported by a \u00a375,000 grant from the UK Government, is a strategic move to transform Ho Chi Minh City into ASEAN's leading health innovation centre.
The Broad One Health Endectocide-based Malaria Intervention in Africa project (BOHEMIA) begins its mass drug administration (MDA) activities in Kenya\u2019s Kwale County. The MDA in Kenya is being implemented by the KEMRI-Wellcome Trust Research Programme and led by co-principal investigators Dr Marta Maia and Dr Joseph Mwangang
An estimated 95,000\u2013167,000 inpatients at English National Health Service (NHS) hospitals caught SARS-CoV-2 while in hospital during England\u2019s \u2018second wave\u2019 of COVID-19, between June 2020 and March 2021, reports a study in Nature. The findings reveal the scale of hospital transmissions and highlight contributing factors, such as a limited number of single rooms.
Professor Philippe Gu\u00e9rin, IDDO and WWARN\u2019s Director, has been awarded the Bailey K. Ashford Medal for his \u201cdistinguished\u201d work in tropical medicine.
In collaboration with Ho Chi Minh City's healthcare sector, OUCRU has successfully identified the primary agent causing the outbreak of pink eye disease. Testings revealed an unexpected finding: enterovirus was the primary agent, contrary to previous reports from Vietnam wherein adenovirus was the culprit.
We were delighted to hear that MORU Deputy Director of MORU and Head of Malaria & Critical Illness, Prof Arjen Dondorp, has been awarded the highly prestigious 2023 George Macdonald Medal!! This medal recognises outstanding individual contribution for conducting research leading to significant improvements in health in the tropics. It is a joint award from the London School of Hygiene & Tropical Medicine (LSHTM) and the Royal Society of Tropical Medicine & Hygiene (RSTMH).
An international consortium of multidisciplinary researchers and specialists has developed a new method to counter the problem of COVID-19 vaccine falsification.
On 28 Sept, MORU Malaria Clinical Researcher Bipin Adhikari received a 2023 Emerging Leaders Award from the Royal Society of Tropical Medicine and Hygiene (RSTMH) to recognise his significant contributions in leadership and service, including mentoring and capacity building, to the fields of tropical medicine and global health.
The ACT HIV trial conducted by NDM\u2019s Oxford University Clinical Research Unit (OUCRU), investigated the effectiveness of dexamethasone in reducing death, disability, and other complications in HIV-positive adults with tuberculous meningitis.
The two-day meeting aimed to foster discussion between policy makers, practitioners and academics on the role of hospitals in the context of global efforts to ensure Universal Health Coverage. The meeting paid special attention to the roles of \u2018district hospitals\u2019 in low and middle-income countries while exploring how hospital care is evolving in high and low-income settings in response to shared global opportunities and challenges.
Professor Alan Bernstein has been appointed as the new head of Oxford Global Health, which will bring together and showcase the breadth of global health research across the University of Oxford.
On October 7th, we had the privilege of hosting a live webinar together with the Vietnamese Psychotherapy Association (VnPA) and Medisetter, titled \u201cMental Healthcare for Carers: We Support the Supporters!\u201d in honour of World Mental Health Day 10th October 2023.
October 10th is World Mental Health Day. This year, the global theme, \u201cOur Minds, Our Rights,\u201d emphasises the universal right to access mental healthcare services as part of basic healthcare, which is considered one of our fundamental human rights.
After the successful completion and positive results from the Phase I (Kenya) and II (Burkina Faso) R21 vaccine trials, researchers have now published the results of the Phase III trial ahead of peer review.
In the first ever direct comparison between the two leading COVID antivirals molnupiravir and nirmatrelvir (Paxlovid\u00ae), researchers report in this week\u2019s Lancet Infectious Diseases that while both drugs worked, nirmatrelvir (Paxlovid\u00ae) was more effective, clearing the virus from the throat more rapidly than molnupiravir.
The University of Oxford has once again topped the Times Higher Education World University Rankings as the best university in the world for a record eighth consecutive year. The rankings \u2013 announced in Sydney, Australia today \u2013 rate 1,904 universities from 108 countries around the world.
Analysis of data from more than 6,800 patients located across 16 countries has supported the need to increase the dose of the antimalarial drug, primaquine, in Plasmodium vivax malaria endemic countries.
The Decolonisation and Global Health Research Exchange Network led by Sassy Molyneux and Dorcas Kamuya, convened a meeting in Kilifi on 29th \u2013 31st August 2023. The meeting brought together 20 participants from Kenya, Ghana, South Africa, Malaysia, UK and Australia.
We are delighted to announce that three of our researchers have been awarded the Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.
The Africa Oxford Initiative (AfOx) is delighted to introduce the 2023 cohort of AfOx graduate scholars at the University of Oxford. The 45 AfOx scholars are from 11 African countries spread across Northern, Eastern, Middle, Southern and Western Africa. Over 66 % of the 2023 AfOx Graduate scholars are female.
A study coordinated by NDM researchers published in BMC Medicine explores the factors predicting higher mortality in pregnant women with severe malaria and describes how severe falciparum malaria in pregnancy affects foetal health and mortality.
A new study published in The Lancet Global Health highlights the devastating impact of the COVID-19 pandemic on tuberculosis (TB) control in Indonesia, the nation with the second highest TB burden globally and the second highest burden of COVID-19 in the Asian region.
A special issue of the Philosophical Transactions of the Royal Society B on challenges and opportunities in the fight against neglected tropical diseases has been released today. This special issue, compiled and edited by Kathryn Forbes, Maria-Gloria Bas\u00e1\u00f1ez, D\u00e9irdre Hollingsworth and Roy M. Anderson, celebrates progress made since the 2012 London Declaration on NTDs and discusses challenges currently faced to achieve these goals.
The ABACUS II Consortium, which includes the Medicine Quality Research Group, published a new viewpoint calling for the standardisation of antibiotics appearance and better information around usage. Changes to the appearance of antibiotic medicines could help avoid confusion and reduce misuse. These measures could help reduce antibiotic resistance, an urgent and global problem that is growing every year.
Four major clinical trial networks, including Oxford University Clinical Research Unit, The Global Health Network, hosted by NDM\u2019s Centre for Tropical Medicine and Global Health, based in low-resource settings are embarking on an exciting partnership with the Good Clinical Trials Collaborative (GCTC) to enhance clinical research in low-resource settings.
In a research letter published in The Lancet, the authors including Professor Philippe Guerin, Director of the Infectious Diseases Data Observatory, hosted by NDM\u2019s Centre for Tropical Medicine and Global Health, emphasised the critical need for equity in the allocation of research funding, especially in the context of epidemic response efforts.
The KEMRI-Wellcome Trust Research Programme from NDM has participated in a new European-African consortium to improve the way infections in newborns are treated. This project, called SNIP-AFRICA, aims to reduce mortality among neonates in hospitals with sepsis in Africa, in an era of increasing antimicrobial resistance.
According to the World Health Organisation, 10-15% of Vietnam\u2019s population is estimated to have viral hepatitis, including 1,07 million people who have Hepatitis C. Over 90% of those who have Hepatitis C are not aware of their positive status. OUCRU, the Hospital for Tropical Diseases (Ho Chi Minh City), and Vietnam\u2019s National Hospital for Tropical Diseases (Hanoi) have been collaborating on Hepatitis C clinical trials since 2018. Our research is centred around predictive factors for selecting persons who could be successfully treated with shorter durations of antiviral therapy for Hepatitis C.
The second annual FORESFA meeting, held in Edinburgh, stimulated discussion on forensic investigations of falsified medicines and engagement with potential implementers.
A new WWARN study, which looked at the variability in white blood cell (WBC) count in patients with uncomplicated malaria, found that using the assumed value of WBC in the calculation of parasite density led to a significant underestimation of parasite count for children and potentially sub-optimal treatment.
The Global Health Network Conference Proceedings 2022 \u2013 a collection of abstracts for the \"Enabling Health Research in Every Healthcare Setting Conference\", held on 24\u201325 November 2022 at the University of Cape Town, South Africa \u2013 are now published.
KWTRP hosted journalists from South Africa, Zambia, Rwanda, Uganda, and Kenya who visited the programme for a tour that aimed to enrich the journalists\u2019 training experience as part of a science communication training workshop for journalists in Mombasa. The team interacted with Dr Eunice Nduati who presented on IAVI work and they toured the research labs. The training will empower the journalists to communicate scientific concepts accurately and effectively to a broader audience.
KWTRP hosted the Improving Hypertension Control in Rural Africa (IHCoR) NIHR Global Health Research Group meeting dubbed the Kilifi Dialogues. The meeting brought together more than 30 leading researchers from various parts of the world to discuss the landscape of hypertension research in sub-Saharan Africa.
Over 50 students and research staff across 11 departments attended a one-day DPhil forum on implementation science and health systems research on July 10th, organised by the Health Systems Collaborative group, NDM-Centre for Global Health Research with support from the Oxford Global Health and Care Systems Society.
Digital health and artificial intelligence have the potential to transform healthcare, making health care management more efficient and accessible. However, a new paper by Ho Quang Chanh et al, detailed why engagement with policymakers, local patients and healthcare workers, and integrating with local systems and practice are crucial to ensure that digital health technologies can thrive in low- and middle-income settings.
Professor Ali Ghufron Mukti, the President Director of the Indonesian Social Security Administering Body for Health (BPJS Kesehatan) visited the Nuffield Department of Medicine on 29th June 2023. He was hosted by colleagues within the Health Systems Collaborative group, Centre for Global Health Research, which shares the overall departmental vision of Universal Health.
This year\u2019s School Leavers Attachment Scheme (SLAS) cohort have successfully concluded. The cohort included 9 students drawn from secondary schools in Kilifi who scored highest in aptitude tests and interviews. The 3-month attachment, which started from 1st March to 31st May, involved two-week long rotations in the HSRE, Neuro, ICT, Labs, Wards and ED departments and bi-weekly tutorials.
The OUCRU Indonesia project, \u201cImproving access to skincare through teledermatology in Eastern Indonesia\u201d, is one of five laureates selected this year from 193 applications in 66 countries by an independent scientific committee of five dermatologists and ILDS board members.
IHTM Course Adviser and lecturer, Dr Alice Norton, has led a highly collaborative effort to develop and launch a new tool for agencies funding global clinical trials \u2013 the GloPID-R Funders Living Roadmap.
![\"LMIC](\"https://www.tropicalmedicine.ox.ac.uk/news/iddo-part-of-the-cercle-coalition-fighting-infectious-diseases-beyond-covid/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n